Photobiomodulation (PBM) irradiation enhances the therapeutic potential of hMSC spheroids for neural repair
Chang SY., Hong N., Choi JE., Ahn JC., Lee MY.
Laboratory Study on Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Front Cell Neurosci (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Front Cell Neurosci (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41696652
- PMCID
- PMC12894004
- DOI
- 10.3389/fncel.2026.1728579
Abstract (original English)
Neural regeneration remains a critical goal in regenerative medicine, especially for treating central nervous system injuries such as stroke, spinal cord injury, and neurodegenerative diseases. Mesenchymal stem cells (MSCs) have shown therapeutic potential through their capacity for differentiation and paracrine signaling; however, their clinical application is limited by low survival and engraftment rates. In this study, we investigated whether the therapeutic efficacy of human MSC (hMSC) spheroids could be enhanced through photobiomodulation (PBM). hMSCs were aggregated into three-dimensional spheroids and divided into four experimental groups: (1) untreated control spheroids, (2) spheroids treated with 660 nm PBM, (3) spheroids treated with 850 nm PBM, and (4) spheroids co-cultured with primary rat cortical neurons subjected to oxidative stress using hydrogen peroxide (H₂O₂). The PBM groups were exposed to red (660 nm) or near-infrared (NIR; 850 nm) light for 10 min. Neuronal viability and axonal regeneration were assessed. Our results demonstrated that PBM-treated hMSC spheroids significantly increased neuronal survival and axonal outgrowth compared to H₂O₂-only controls, particularly under high oxidative stress conditions. Notably, spheroids treated with 850 nm PBM exhibited the most robust neuroprotective effects. These findings suggest that PBM enhances mitochondrial act
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisEurope PMC
Stem cell therapy for ischemic stroke: neuroimaging approaches and evidence from a systematic review
Meta-analysis on Stroke Research, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev - Level AMeta-analysisEurope PMC
Efficacy and Potential Mechanisms of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Ischemic Stroke in Animal Models: A Meta-Analysis
Meta-analysis on Stroke Research, published in CNS Neurosci Ther (2025) — summary generated from the PubMed abstract.
- 2025
CNS Neurosci Ther5 citations - Level AMeta-analysisPubMed
The inconclusive superiority debate of allogeneic versus autologous MSCs in treating patients with HFrEF: a systematic review and meta-analysis of RCTs.
Meta-analysis with a reported sample of 1184 on Cardiovascular Disease, Stroke Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 1184
Stem Cell Res Ther2 citations - Level ASystematic ReviewEurope PMC
In vitro and In vivo Studies on Mesenchymal Stem Cells for Ischemic Stroke Therapy: A Scoping Review of The Therapeutic Effect
Systematic Review on Stroke Research, published in Stem Cells Cloning (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cells Cloning